Nutrition Research
Volume 28, Issue 4 , Pages 239-244 , April 2008

Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease

  • Yukiko Ueda

      Affiliations

    • Department of Food Science and Nutrition, Faculty of Human Life and Environment, Nara Women’s University, Kitauoyanishimachi, Nara City 630-8506, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 742 20 3786; fax: +81 74220 3786.
  • ,
  • Yuko Kawakami

      Affiliations

    • Department of Human Nutrition, Faculty of Contemporary Life Science, Chyugokugakuen University
  • ,
  • Daisuke Kunii

      Affiliations

    • National Institute of Health and Nutrition
  • ,
  • Hiroyuki Okada

      Affiliations

    • Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry
  • ,
  • Masami Azuma

      Affiliations

    • Department of Health Science, Graduate School of Education, Osaka Kyoiku University
  • ,
  • Duc Son N.T. Le

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health
  • ,
  • Shigeru Yamamoto

      Affiliations

    • Graduate School of Humanities and Sciences, Ochanomizu University

Received 13 October 2007 ,Revised 7 January 2008 ,Accepted 4 February 2008.

References 

  1. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel Disease. Gastroenterol Clin North Am. 1999;28(2):255–281
  2. Whelan G. Epidemiology of inflame bowel diseases. Med Clin North Am. 1990;74:1–12
  3. Yang SK, Loftus WJ, Sandborn EV. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7:260–270
  4. Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T, et al. Dietary risk factors for inflammatory bowel disease a multicenter case-control study in Japan. Inflamm Bowel Dis. 2004;11:154–163
  5. Elson CO, Genes M. T cells—new therapeutic targets in Crohn's disease. N Engl J Med. 2002;346:614–616
  6. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scan. 1980;208:401–406
  7. Donowitz M. Arachidonic acid metabolites and their role in inflammatory bowel disease. Gastroenterology. 1985;88:580–587
  8. Awane M, Li DJ, Andres PG, Reinecker HC. NF-kappa B–inducing kinase is a common mediator of IL-17-, TNF-alpha, and IL-1 beta–induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 1999;162(9):5337–5344
  9. Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984;86:453–460
  10. Budowski P, Crawford MA. a-Linolenic acid as a regulator of the metabolism of arachidonic acid: dietary implications of the ratio, n-6: n-3 fatty acid. Proc Nutr Soc. 1985;44:221–229
  11. Adam O, Wolfram G, Zollner N. Effect of a-linolenic acid in the human diet of linoleic acid metabolism and prostaglandin biosynthesis. F Lipid Res. 1986;27:421–426
  12. Kinsella JE, Lokesh B, Broughton S, Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition. 1990;6:24–44
  13. Robinson DR. Alleviation of autoimmune disease by dietary lipids containing omega-3 fatty acids. Rheum Dis Clin North Am. 1991;17:213–222
  14. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63(5):741–745
  15. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996;334:1557–1560
  16. Campbell JM, Fahey GC, Lichtensteiger CA. An enteral formula containing fish oil, indigestible oligosaccharides, gum Arabic and antioxidants affects plasma and colonic phospholipids fatty acid and prostaglandin profiles in pigs. J Nutr. 1997;127:137–145
  17. Mills DE, Murthy M, Galey WR. Dietary fatty acids, membrane transport and oxidative sensitivity in human erythrocytes. Lipids. 1995;30:657–663
  18. Skeaff MC, Hodson L, McKenzie EJ. Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr. 2006;136:565–569
  19. Bjerve KS, Brubakk AM, Fougner KJ. Omega-3 fatty acids: essential fatty acids with important biological effects, and serum phospholipids fatty acid as markers of dietary omega-3 fatty acid intake. Am J Clin Nutr. 1993;57:801s–806s
  20. Schachter H, Kirsner JB. Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology. 1975;68:591–600
  21. A diagnosis standard examination committee of obesity by JASSO: a committee report about a judgment of new obesity and a diagnosis standard of obesity. Journal of the Study of Obesity. 2000;6:18–28
  22. Suzuki K, Sasagawa T, Okita M, Fujiwara Y, Saito M, Abe Y. Development of new simplified-food frequency method for use in the surveillance on lifestyle in order to promote healthy condition in Okayama Prefecture, computed by Microsoft Excel. Bull Facul Health Welfare Sci, Okayama Prefec Univ. 1996;3:143–153
  23. Dumas BT, Watson WA, Biggs HG. Albumins standard and the measurement of serum albumin with bromcresol green. 1971. Clin Chim Acta. 1997;3:21–30
  24. Hanahan DJ, Ekholm JE. The preparation of red cell ghosts (membrane). Methods in enzymol. 1974;31:168–172
  25. Blight EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–917
  26. Okita M, Gaudette DC, Mills GB, Holub BJ. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine (lysoPC) in ovarian cancer patients. Int J Cancer. 1997;71:31–34
  27. Okita M, Sasagawa T, Kotani M. Green vegetable juice increases polyunsaturated fattty acid of erythrocyte membrane phospholipids in hypercholesterolaemic patients. Asia Pac J Clin Nutr. 2000;9:309–313
  28. SPSS Inc. SPSS for Windows, Release 11.5; 2000. Chicago.
  29. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495–505
  30. Calder PC. N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale?. Nutr Res. 2001;21:309–341
  31. Pacheco S, Hillier K, Smith C. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease. Clinical Science. 1987;73:361–364
  32. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroenterology. 1988;95:11–17
  33. Capritso E, Mingrone G, Addolorato G, Greco AV, Gasbarrini G. Metabolic features of inflammatory bo 1 disease in a remission phase of the disease activity. J Intern Med. 1998;243:339–347
  34. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in reemission. Am J Clin Nutr. 1998;67:819–820
  35. Hawkey CJ, Boughton-Smith NK, Whittle BJ. Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci. 1985;30:1161–1165
  36. Brenner RR. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res. 1981;20:41–47
  37. Hill EG, Holman RT. Effect of dietary protein level upon essential fatty acid deficiency. J Nutr. 1980;110:1057–1060
  38. Tomas ME, Mercuri O, Rodrigo A. Effects of dietry protein and EFA deficiency on liver D5, D6 and D9 desaturase activities in the early developing rat. J Nutr. 1980;110:595–599

PII: S0271-5317(08)00033-X

doi: 10.1016/j.nutres.2008.02.005

Nutrition Research
Volume 28, Issue 4 , Pages 239-244 , April 2008